3 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Dianhydrogalactitol: new trials by email Literature Review of Dianhydrogalactitol trials Research Report on Dianhydrogalactitol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer VAL-083, Dianhydrogalactitol - Ovarian Cancer | Phase 1 / Phase 2 | Withdrawn | DelMar Pharmaceuticals, Inc. | 2021-03-01 | 2019-10-18 | |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Temozolomide, Lomustine, Regorafenib - Glioblastoma | Phase 2 / Phase 3 | Recruiting | Global Coalition for Adaptive Research | 2250 | 2019-07-30 | 2026-11-02 |
| Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression VAL-083 (Dianhydrogalactitol) - Glioma, Glioblastoma | Phase 2 | Completed | Kintara Therapeutics, Inc. | 29 | 2017-12-17 | 2025-09-04 |
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM VAL-083, Dianhydrogalactitol, Physician's Choice of Salvage Therapy - temozolomide, Physician's Choice of Salvage Therapy - lomustine - Glioblastoma Multiforme, Glioblastoma | Phase 3 | Terminated | DelMar Pharmaceuticals, Inc. | 2 | 2017-10-27 | 2025-09-04 |
| Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting VAL-083, Dianhydrogalactitol - Glioma, Glioblastoma | Phase 2 | Completed | Kintara Therapeutics, Inc. | 118 | 2017-01-20 | 2025-08-29 |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma VAL-083 (Dianhydrogalactitol) - Glioma, Glioblastoma | Phase 1 / Phase 2 | Completed | Kintara Therapeutics, Inc. | 55 | 2011-10-01 | 2025-08-29 |
Glioblastoma (5) · Brain Neoplasms (4) · Glioma (4) · Ovarian Neoplasms (1) · Recurrence (1)
Kintara Therapeutics, Inc. (3) · DelMar Pharmaceuticals, Inc. (2) · Global Coalition for Adaptive Research (1)
United States (5) · Australia (1) · Canada (1) · China (1) · France (1) · Germany (1) · Switzerland (1)
Nicholas Butowski, M.D. (2) · Barbara O'Brien, M.D. (1) · Bradley J Monk, M.D. (1) · Chen Zhong-ping, M.D., Ph.D. (1) · Gerald Falchook, M.D. (1) · Howard A Burris, M.D. (1) · Manish Patel, M.D. (1) · Sani Kizilbash, M.D. (1) · Tim Cloughesy, MD (1)